Last reviewed · How we verify
Aadipose-Derived Mesenchymal Stem Cells
At a glance
| Generic name | Aadipose-Derived Mesenchymal Stem Cells |
|---|---|
| Also known as | MitoCell |
| Sponsor | Taiwan Mitochondrion Applied Technology Co., Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease (PHASE1)
- Adipose-tissue-derived Total-Stromal-cells (TOST) Therapy in Knee Osteoarthritis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: